Novavax (NVAX) Sales of Property, Plant and Equipment (2012 - 2026)

Novavax (NVAX) Sales of Property, Plant and Equipment (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Novavax 1.49 Bn 931.98 Mn 108.82 Mn 39.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 39.75 Mn
Mar 31, 2026 39.75 Mn
Dec 31, 2015 18,000.00
Dec 31, 2015 18,000.00
Sep 30, 2014 27,000.00
Sep 30, 2014 27,000.00
Dec 31, 2013 33,000.00
Dec 31, 2013 33,000.00
Sep 30, 2013 2,000.00
Sep 30, 2013 2,000.00
Jun 30, 2013 30,000.00
Jun 30, 2013 30,000.00
Mar 31, 2013 51,000.00
Mar 31, 2013 51,000.00
Dec 31, 2012 6,000.00
Dec 31, 2012 6,000.00
Sep 30, 2012 151,000.00
Sep 30, 2012 151,000.00